Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A prospective study on the application of Multi-target Stool FIT-DNA Test (ColoClear) in colorectal cancer screening and the practical verification of genetic and lifestyle factors

ABSTRACT: Interventions: Gold Standard:colonoscopy;Index test:Multi-target Stool FIT-DNA Test (ColoClear) ; Fecal immunochemical test(Pupu Tube) Primary outcome(s): Sensitivity;Specificity;Positive predictive value;Negative predictive value;Coincidence Rate;Morbidity Study Design: Cohort study

DISEASE(S): Colorectal Tumor

PROVIDER: 2662204 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Application value of multi-target stool FIT-DNA test (ColoClear) in patients with early colorectal cancer and precancerous lesions and their first-degree relatives: a prospective study

Project description:Interventions: Gold Standard:Colonoscopy.;Index test:Multi-target stool FIT-DNA test (ColoClear). Primary outcome(s): Sensitivity;Specificity;Positive predictive value;Negative predictive value Study Design: Cohort study

| 2725412 | ecrin-mdr-crc

Artificial intelligence assisted endocytoscopy in real-time diagnosis of early colorectal cancer

Project description:Interventions: Gold Standard:Pathological test;Index test:1. Endoscopy; 2. Artificial intelligence real-time diagnosis system. Primary outcome(s): Diagnostic accuracy;Sensitivity;Specificity;Positive predictive value;Negative predictive value Study Design: Sequential

| 2725610 | ecrin-mdr-crc

Performance of new biomarkers and technologies for colorectal cancer screening

Project description:Interventions: Gold Standard: Taking colonoscopy together with pathological examination results as the gold standard.;Index test:Detection of miR-92a in stool samples; Detection of Septin9 in plasma samples; Detection of FIT-DNA in stool samples; Fecal immunochemical test. Primary outcome(s): Sensitivity;Specificity;Positive predictive value;Negative predictive value Study Design: Diagnostic test for accuracy

| 2662086 | ecrin-mdr-crc

Molecular Diagnostic Program for Early Screening of Colorectal Cancer in China

Project description:Interventions: Gold Standard:Pathological diagnosis;Index test:Early screening model of colorectal cancer Primary outcome(s): Sensibility;Specificity;Positive Predictive Value;Negative Predictive Value;Tissue Biomarker Methylation;Tissue Biomarker Mutation;Blood Biomarker Methylation;Stool Mutation;Stool Methylation;Stool Bacteria Study Design: Sequential

| 2688309 | ecrin-mdr-crc

Excavation and clinical verification of early warning biomarkers for hand-foot syndrome induced by capecitabine

Project description:Interventions: Gold Standard:Clinical outcome;Index test:Study on endogenous biomarkers by targeted metabonomics Primary outcome(s): SEN, SPE, ACC, AUC of ROC, PPV, NPV Study Design: Sequential

| 2698756 | ecrin-mdr-crc

Stool DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer

Project description:Interventions: Gold Standard:colonoscopy;Index test:Stool DNA methylation biomarkers. Primary outcome(s): accuracy Study Design: Diagnostic test for accuracy

| 2680588 | ecrin-mdr-crc

Stool DNA Testing for opportunistic screening of High-risk Colorectal Cancer population

Project description:Interventions: Gold Standard:Histopathological diagnosis of colorectal cancer to be the gold standard;Index test:1. Human sdc2 gene methylation detection kit; 2. Fecal Immunochemical Test. Primary outcome(s): Stool DNA Testing;colonoscopy;SPE, SEN, ACC, AUC of ROC Study Design: Sequential

| 2682966 | ecrin-mdr-crc

Altered fecal small RNA profiles in colorectal cancer reflect gut microbiome composition in stool samples

Project description:Dysbiotic configurations of the human gut microbiota have been linked with colorectal cancer (CRC). Human small non-coding RNAs are also implicated in CRC and recent findings suggest that their release in the gut lumen contributes to shape the gut microbiota. Bacterial small RNAs (bsRNAs) may also play a role in carcinogenesis but their role is less explored. Here, we performed small RNA and shotgun sequencing on 80 stool specimens of patients with CRC, or adenomas, and healthy subjects collected in a cross-sectional study to evaluate their combined use as a predictive tool for disease detection. We reported a considerable overlap and correlation between metagenomic and bsRNA quantitative taxonomic profiles obtained from the two approaches. Furthermore, we identified a combined predictive signature composed by 32 features from human and microbial small RNAs and DNA-based microbiome able to accurately classify CRC from healthy and adenoma samples (AUC= 0.87). In summary we reported evidence that host-microbiome dysbiosis in CRC can be observed also by altered small RNA stool profiles. Integrated analyses of the microbiome and small RNAs in the human stool may provide insights for designing more accurate tools for diagnostic purposes.

2019-08-30 | GSE132236 | GEO

Establishment and Verification of Endoscopic Prediction Model for the Nature and Depth of Invasion of Colorectal Tumors and Exploration of New Diagnostic Methods

Project description:Interventions: Gold Standard:Definite diagnosis by pathology;Index test:Endoscopic Prediction Model for the Nature and Depth of Invasion of Colorectal Tumors and Exploration. Primary outcome(s): Endoscopic characteristics;SEN, SPE, ACC, AUC of ROC Study Design: Sequential

| 2701950 | ecrin-mdr-crc

Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China

Project description:The primary objective is to determine sensitivity, specificity, positive predictive value and negative predictive value of a bi-target stool DNA testing (the methylation status of SDC2 and SFRP2) for colorectal cancer and advanced precancerous neoplasm(including advanced adenoma and advanced serrated lesions) screening, using colonoscopy as the reference method. Lesions will be confirmed as malignant or precancerous by histopathologic examination. The secondary objective is to compare the performance of the bi-target stool DNA testing to a commercially available fecal immunochemical test (FIT) assay, both with respect to cancer and advanced precancerous neoplasm. Lesions will be confirmed as malignant or precancerous by colonoscopy and histopathologic examination.

| 2348965 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data